SCI-ART LAB

Science, Art, Litt, Science based Art & Science Communication

Q: What is Translational Medicine ?

Krishna:  Translation Medicine is a branch of biomedical and public health research that converts laboratory discoveries into clinical applications that improve human health. 

It is a research discipline connecting basic science discoveries from the laboratory with the clinic and back again. It aims to use scientific insights and learnings to drive the development of patient-centred solutions and help promising treatments reach patients.

Lab research generates lots of data  but all that is not very appropriate with regard to patients. 

Translational medicine is translating  relevant research for use in bedside. Like the science communicators interpreting lab science to the laymen, translational researchers adapt the clinical therapy from research  to the benefit of the community at large.

It is a  cross-disciplinary field managed by a collaborative team of physician-scientists, translational researchers, science communicators, pharmacologists, biomarker specialists, and clinical operations experts rather than a single medical specialty or individual doctor. 

This picture is AI generated and licensed by GOOGLE

Key Professionals and Teams Involved:
Physician-Scientists / Clinicians: Medical doctors who treat patients while also conducting research, helping bridge actual patient needs at the "bedside" back to laboratory questions. 
Translational Researchers & Basic Scientists: Biologists, geneticists, and chemists working in laboratories ("the bench") who study disease mechanisms and create early-stage compounds or tools. 
Pharmacologists & Pharmacometricians: Specialists who use quantitative modelling to predict how drugs behave, optimize dosing regimens, and streamline early trials.
Biomarker and Imaging Scientists: Experts who develop molecular tests, diagnostics, and non-invasive imaging techniques to measure how a therapy affects the body. 
Regulatory and Clinical Trial Teams: Professionals who manage safety evaluations, Phase I–III clinical trials, and compliance with medical authorities. 
Where translational medicine takes place:
Academic & Research Medical Centres: Institutions like the Mayo Clinic, Stanford Medicine, and major university hospitals that run dedicated translational science departments and labs. 
In India PD Hinduja Hospital, AIIMS, Delhi, PGIMER Chandigarh, CMC Vellore and  
in Hyderabad , Asian Institute of Gastroenterology, Apollo Hospitals,
Basavatarakam Indo American Cancer Hospital & Research Institute (BIACH & RI)
and several other hospitals too are into this field.
Biopharmaceutical and Life Sciences Companies: Corporate R&D and translational departments—such as those at Novartis or Servier— work to move molecules from animal models into human clinical trials ("bench-to-bedside"). 
Often described as moving science "from bench to bedside" (and back again), it bridges the gap between basic laboratory research (cell cultures, animal models, and genetics) and real-world medical practice (diagnostic tools, drugs, and treatments).
Purpose:
 

Better Prevention: 

Translating scientific insight into strategies that prevent disease before it takes hold.

Sharper Diagnosis:

Bringing new tools and biomarkers from the laboratory into accurate, earlier diagnosis.

Effective Therapies:

Accelerating the path from promising research to treatments that reach the patients who need them.

Core pillars and goals
Translational medicine is an interdisciplinary branch of the biomedical field supported by three main pillars: bench side, bedside, and community.
Bench side: Basic laboratory and preclinical research to understand disease mechanisms. Fundamental laboratory research that generates the discoveries, mechanisms, and scientific knowledge on which new approaches are built.
Bedside: Clinical trials and patient-oriented research to test the safety and effectiveness of new therapies. Clinical practice that applies research to patient care — and returns real-world observations to the laboratory to shape new questions.
Community (end user): Translating proven interventions into public health policies, education, and standard medical care. Patients, the public, and practitioners — the ultimate beneficiaries of translational medicine and a vital source of insight, feedback, and direction.
The main goal of translational medicine is to combine disciplines, resources, expertise, and techniques within these pillars to promote enhancements in prevention, diagnosis, and therapies. It is a highly interdisciplinary field whose primary aim is to bring together assets of many kinds — across each pillar — to significantly improve the global healthcare system.
Translational medicine is vital because
It accelerates timelines: It reduces the time and cost required to turn a scientific breakthrough into a usable medicine.
Personalized medicine: It helps identify specific patient sub-populations most likely to respond to a targeted treatment, increasing success rates and reducing clinical risks.
Bi-directional feedback: Clinical observations from treating patients are sent back to the laboratory to refine future research and solve remaining medical questions. 

Why do we need a special field for this?

Not all doctors are familiar with research although some of them consult medical journals to get updated.

There is no single national census tracking the exact percentage of all practicing doctors in India who actively engage in research. However, regional surveys and studies indicate that while over 50% to nearly 58% of Indian doctors and medical students 'express an interest in or positive aptitude for research', active participation and regular publication rates are significantly lower. 

Smaller fractions progress to peer-reviewed output—roughly 7.43% published an original research article, 7.43% published a case report/series, and 6.44% published a review article in that cohort. Surveys of practicing physicians note that although many publish a case report or analysis at some point, only a small percentage are dedicated, active physician-researchers. (1)

A broader assessment of Indian medical colleges highlighted that 57% of accredited medical institutions did not have a single biomedical research paper published in Scopus-indexed journals during the period evaluated. (2)

Physicians cite heavy clinical workloads, busy schedules (34.2%), lack of journal access (43.9%), and a scarcity of formal training or mentorship (37.4%) as primary obstacles. (3)

So translational medicine and science communicators are vital to bridge the gap between labs and medical centres to treat patients effectively. 

Several doctors in India tell me they follow and read my articles too to get updated and get benefitted.

Footnotes:

1. https://thegjms.org/india-needs-more-physician-scientists-and-promo...

2. https://www.cps.iitb.ac.in/research-in-indian-medical-colleges-look...

3. https://pmc.ncbi.nlm.nih.gov/articles/PMC7586595/

Views: 20

Replies to This Discussion

18

RSS

Badge

Loading…

© 2026   Created by Dr. Krishna Kumari Challa.   Powered by

Badges  |  Report an Issue  |  Terms of Service